Cantel Medical Corp. (CMN) is Initiated by Needham to Hold

Cantel Medical Corp. (CMN) was Initiated by Needham to “Hold”. Needham advised their investors in a research report released on Aug 24, 2016.

On the company’s financial health, Cantel Medical Corp. reported $0.44 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Jun 8, 2016. Analyst had a consensus of $0.36. The company had revenue of $173.70 million for the quarter, compared to analysts expectations of $163.16 million. The company’s revenue was up 22.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.35 EPS.

Cantel Medical Corp. opened for trading at $72.87 and hit $73.69 on the upside on Tuesday, eventually ending the session at $73.28, with a gain of 0.81% or 0.59 points. The heightened volatility saw the trading volume jump to 1,16,204 shares. Company has a market cap of $3,056 M.

In a different news, on Jun 21, 2016, Jorgen B Hansen (President and COO) sold 2,000 shares at $72.44 per share price. According to the SEC, on Jun 14, 2016, Eric W Nodiff (EVP and General Counsel) sold 2,574 shares at $72.97 per share price. On Jun 14, 2016, Mark N. Diker (director) sold 7,000 shares at $73.30 per share price, according to the Form-4 filing with the securities and exchange commission.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy Water Purification and Filtration Healthcare Disposables Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems disinfectants detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services filtration and separation products and disinfectants sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems sterilants/disinfectants and dialysate concentrates. Its Specialty Packaging segment includes specialty packaging and thermal control products as well as related compliance training.

Cantel Medical Corp.

Leave a Reply

Cantel Medical Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cantel Medical Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.